Celebrex Buyers Seek Class Cert. In Pfizer Antitrust Suit
Purchasers of popular painkiller Celebrex on Wednesday asked a Virginia federal court to certify as a class action its suit against Pfizer accusing the drug giant of using fraudulent patents to...To view the full article, register now.
Already a subscriber? Click here to view full article